30 under 30 recognition for Enterprise Plus company

Redbrick Molecular Directors Andy Hogben and James Gibbons have been named in the 2018 Forbes 30 under 30 in Europe list.

Redbrick Molecular, a member of the Royal Society of Chemistry’s EnterprisePlus scheme, was highlighted in the entrepreneurial list under Science and Healthcare for its efforts to help attain scientific and economic impact for UK academic chemistry. The company, a spin out from The Universities of Sheffield and Leeds, uses methodologies developed by academics to manufacture the building block and fragment chemicals that underpin drug discovery and development.

"Our whole purpose is to translate chemistry from academia into industry as quickly and efficiently as possible," says Andy Hogben, a member of the Royal Society of Chemistry and Chartered Chemist. "We were so pleased to see Redbrick Molecular included in the Forbes list as our aims are a bit different to traditional spinout companies. We’re entirely owned by our University-members, which means that all our profits will be used to fund further academic research in chemistry."

The Forbes 30 Under 30 are in part selected on their entrepreneurial approach and the likelihood of delivering change to their field. "These principles really underpin Redbrick Molecular," Andy says, "and we’re really fortunate to be working with some talented and forward-looking academics at Leeds, Sheffield and further afield."